Bryan Ennis

Chief Quality Officer at Boston Technology Research

Bryan Ennis has a diverse work experience spanning multiple industries. Bryan is currently the CEO at Sware since June 2019. Prior to this, they worked at Veeva Systems from April 2013 to April 2019, holding roles such as Director of Global Product Communities and Director of R&D Customer Success. Bryan also served as an Adjunct Professor of Telehealth at Pace University from September 2013 to December 2015. Before that, they were an Enterprise Program Director at NextDocs from January 2012 to April 2013. Bryan's early career includes a role as Global Regulatory Systems and Program Management at Genzyme from July 2004 to January 2012, and they started their professional journey as a National Designer at Price Waterhouse Coopers in 2003.

Bryan Ennis started their education in 1994 at the Manhattan School of Music, where they pursued a field of study in Cello Performance. Bryan attended this institution until 1998 when they completed their studies. Later on, in 1998, Bryan enrolled at the University of Hartford, where they focused on Management Information Systems and Professional & Technical Writing. Bryan attended the University for three years, until 2001. The information provided does not indicate that Bryan obtained any degrees from either institution.

Location

Boston, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Boston Technology Research

Everything you need to manage the compliance of the systems you rely on most. BTR (Boston Technology Research) is a regulatory technology company serving healthcare, life sciences and SaMD. We provide enterprise-wide solutions that automate how companies ensure compliance with domestic and international regulatory requirements. BTR is headquartered in Chelsea, MA with a global workforce located throughout North America, Europe and Asia. BTR was founded by the same leaders who took Veeva and the life sciences industry into the cloud. We’re validation pioneers in the industry transition to Computer Systems Assurance (CSA), building the software needed to actualize the FDA’s vision for Industry 4.0.


Industries

Employees

51-200

Links